Literature DB >> 9869011

Overexpression of vascular endothelin-1 and endothelin-A receptors in a fructose-induced hypertensive rat model.

C C Juan1, V S Fang, Y P Hsu, Y J Huang, D B Hsia, P C Yu, C F Kwok, L T Ho.   

Abstract

OBJECTIVE: To examine the temporal relationship between hyperinsulinemia and hypertension in the fructose-hypertensive rat model and to study the function of endothelin-1 (ET-1) in fructose-induced hypertension.
DESIGN: Since ET-1 induces insulin resistance in conscious rats, we tested the hypothesis that both hyperinsulinemia and hypertension developed in the fructose-hypertensive rat model might be the sequelae of an elevated tissue content of ET-1 and ET(A) receptors.
MATERIALS AND METHODS: Systolic hypertension was induced within 3 weeks in male Sprague-Dawley rats fed on a fructose-rich diet. After continual monitoring of blood pressure and plasma insulin concentrations, the animals were killed at the end of experiment to determine plasma levels of ET-1, the contractile response of aortic rings to ET-1, and ET-1 and ET(A) receptor gene expressions. In a separate experiment, BQ-610 was administered to lower the effect of ET-1 in rats with fructose-induced hypertension.
RESULTS: Compared with control rats given normal chow, the fructose-fed rats developed systolic hypertension after 3 weeks of the diet (127+/-3.7 versus 110+/-5.5 mmHg, P < 0.01) and hyperinsulinemia both before (1 07.1+/-32.5 versus 48.5+/-14.3 pmol/l, P < 0.005) and after (96.6+/-63.7 versus 50.4+/-5.6 pmol/l, P< 0.05) they became hypertensive. Although plasma ET-1 levels did not differ between the rat groups, aortic ring contraction-concentration curves, indicating vessel contractility in response to ET-1, were significantly greater in these rats than in controls (F1,72 = 12.34, P< 0.00077). Messenger RNA extracted from the tail arteries and blotted with both ET-1 and ET(A) probes showed that fructose-fed rats had greater ET-1 and ET(A)-receptor gene expression than control rats. Concomitant administration of BQ-610 to rats fed on a fructose diet significantly reduced the hypertension. Conclusions These findings suggest that elevated vascular expression of ET-1 and ET(A) receptor genes may mediate the development of hypertension and hyperinsulinemia in rats fed a fructose-rich diet

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9869011     DOI: 10.1097/00004872-199816120-00010

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  13 in total

1.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

2.  Differential effects of high consumption of fructose or glucose on mesenteric arterial function in female rats.

Authors:  Sonali Shaligram; Gemma Sangüesa; Farjana Akther; Marta Alegret; Juan C Laguna; Roshanak Rahimian
Journal:  J Nutr Biochem       Date:  2018-04-03       Impact factor: 6.048

3.  Induction of insulin resistance by high-sucrose feeding does not raise mean arterial blood pressure but impairs haemodynamic responses to insulin in rats.

Authors:  Marta Santuré; Maryse Pitre; André Marette; Yves Deshaies; Christian Lemieux; Richard Larivière; André Nadeau; Hélène Bachelard
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 4.  The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension.

Authors:  Linda T Tran; Violet G Yuen; John H McNeill
Journal:  Mol Cell Biochem       Date:  2009-06-18       Impact factor: 3.396

5.  Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats.

Authors:  L T Tran; K M MacLeod; J H McNeill
Journal:  Mol Cell Biochem       Date:  2009-01-13       Impact factor: 3.396

6.  Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia.

Authors:  Kyan J Allahdadi; Tom W Cherng; Hemanth Pai; Ana Q Silva; Benjimen R Walker; Leif D Nelin; Nancy L Kanagy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-30       Impact factor: 4.733

7.  Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-treated rats.

Authors:  Chun Xia Zhao; Xizhen Xu; Yinghua Cui; Peihua Wang; Xin Wei; Shilin Yang; Matthew L Edin; Darryl C Zeldin; Dao Wen Wang
Journal:  J Pharmacol Exp Ther       Date:  2008-11-13       Impact factor: 4.030

8.  The Relation between Fructose-Induced Metabolic Syndrome and Altered Renal Haemodynamic and Excretory Function in the Rat.

Authors:  Mohammed H Abdulla; Munavvar A Sattar; Edward J Johns
Journal:  Int J Nephrol       Date:  2011-07-12

9.  Endothelin Type A Receptor Genotype is a Determinant of Quantitative Traits of Metabolic Syndrome in Asian Hypertensive Families: A SAPPHIRe Study.

Authors:  Low-Tone Ho; Yung-Pei Hsu; Chin-Fu Hsiao; Chih-Tai Ting; Kuang-Chung Shih; Lee-Ming Chuang; Kamal Masaki; John Grove; Thomas Quertermous; Chi-Chung Juan; Ming-Wei Lin; Shu-Chiung Chiang; Yii-Der I Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2013-11-28       Impact factor: 5.555

10.  Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.

Authors:  Amr A A Mahmoud; Shimaa M Elshazly
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.